Efficient aquaporin 1 (Aqp1) disruption by CRISPR/Cas9 in the mouse ciliary body epithelium following intravitreal injection is able to lower IOP and prevent RGC loss in a micro-bead glaucoma mouse model (Wu et al., 2020). Here, AQP1 is linked to glaucoma.